Breaking News
November 13, 2018 - Entasis Therapeutics Announces Zoliflodacin Phase 2 Results Published in The New England Journal of Medicine
November 13, 2018 - Gene changes driving myopia reveal new focus for drug development
November 13, 2018 - $6 million grant to support study of preeclampsia, atherosclerosis links | News Center
November 13, 2018 - Beneficial gut microbes metabolize high-fiber diet to improve heart health in mouse model
November 13, 2018 - Excessive use of social media through visual postings linked to increase in narcissistic traits
November 13, 2018 - Study finds why obesity both fuels cancer growth and helps immunotherapy to kill tumors
November 13, 2018 - Women prefer and invest more in daughters, while men favor sons
November 13, 2018 - With hospitalization losing favor, judges order outpatient mental health treatment
November 13, 2018 - Transgenic rat model may provide new insights into cerebral amyloid angiopathy
November 13, 2018 - Study identifies factors tied to greater risk of advanced liver disease in cystic fibrosis patients
November 13, 2018 - Risk of blindness among premature babies with low levels of blood platelets
November 13, 2018 - A new strategy for combatting antibiotic-resistant infections
November 13, 2018 - Study aims to find which outreach method is more effective at improving cancer screening rates
November 13, 2018 - Insufficient sleep duration linked with unhealthy lifestyle profile among children
November 13, 2018 - IIASA researchers introduce new, simple measure for human wellbeing
November 13, 2018 - Scientists examine FCMs containing silver nanoparticles
November 13, 2018 - Failed DNA repair triggers chromosomal chaos
November 13, 2018 - Food insecurity during pregnancy linked to severity of neonatal abstinence syndrome
November 13, 2018 - Majority of Americans are concerned about health threat posed by antibiotic resistance
November 13, 2018 - Addition of Elotuzumab Ups PFS in Refractory Multiple Myeloma
November 13, 2018 - Study finds women with pregnancy-related nausea, vomiting use marijuana more
November 13, 2018 - Lethal heart rhythm more likely to be found in patients with common heart failure
November 13, 2018 - Study provides new clues to origin and development of multiple sclerosis
November 13, 2018 - Climate change could pose threat to male fertility
November 13, 2018 - Researchers discover how mitochondria deploy a powerful punch against disease-causing bacteria
November 13, 2018 - AHA: Traumatic Childhood Could Increase Heart Disease Risk in Adulthood
November 13, 2018 - Feeling the Burn? | NIH News in Health
November 13, 2018 - Women’s birth canals in Kenya, Korea, Kansas not the same: study
November 13, 2018 - Fecal microbiota transplantation effective against ICI-associated colitis
November 13, 2018 - New physical activity guidelines released that urge people to “move more”
November 13, 2018 - Angiotensin receptor blockers improve sodium excretion in blacks
November 13, 2018 - New project seeks to address alarming injury rate in youth footballers
November 13, 2018 - Fish oil or omega 3 fatty acid supplements can prevent heart attacks finds study
November 13, 2018 - The Human Heart-in-a-Jar That Could One Day Replace Animal Testing
November 13, 2018 - Treat patients’ partners without a doctor visit
November 13, 2018 - Belgian beer landscape mapped using scientific insights
November 13, 2018 - ‘Master key’ gene has links to both ASD and schizophrenia
November 13, 2018 - Gladstone scientists gain new insights into the aging brain
November 13, 2018 - Drug therapy can improve outcomes for acutely ill heart patients
November 13, 2018 - Three landmark studies provide better understanding of sudden cardiac arrest
November 13, 2018 - Cholesterol control revised in the latest AHA/ACC guidelines
November 13, 2018 - Vulnerable young teenagers urgently need better sex education, say researchers
November 13, 2018 - Breakthrough research reveals how deadly pneumococcus avoids immune defenses
November 13, 2018 - Researchers discover possible path forward in preventing cancers tied to two viruses
November 13, 2018 - Wishes can help pediatric patients to get better over time
November 13, 2018 - Janssen Reports Positive Topline Results for FLAIR Phase 3 Study of a Novel, Long Acting Injectable Two-Drug Regimen for the treatment of HIV-1
November 13, 2018 - Experimental compound reduces Gulf War illness-like behavior in mice
November 13, 2018 - Small-stature in rainforest populations may be linked to cardiac adaptations
November 13, 2018 - Study shows how pneumococci challenge the immune system
November 13, 2018 - Simple cysts can be safely ignored, study finds
November 13, 2018 - First fully personalized tissue implant engineered from patient’s own materials and cells
November 13, 2018 - FDA Approves Keytruda (pembrolizumab) in Combination with Carboplatin and Either Paclitaxel or Nab-Paclitaxel for the First-Line Treatment of Patients with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
November 13, 2018 - Scientists take big step toward finding non-addictive painkiller
November 13, 2018 - Diabetes medication reduces risk of heart failure hospitalization
November 13, 2018 - Achieving high follow-up rates for violently injured patient population is feasible
November 13, 2018 - Shortage of specific gene ‘silencing’ molecules linked with pediatric low-grade gliomas
November 13, 2018 - Abx-Resistant Enterobacteriaceae Tied to Clinical Failure in UTI
November 13, 2018 - US approves first new type of flu drug in 2 decades
November 13, 2018 - Is zinc the link to how we think? Some evidence, and a word of warning
November 13, 2018 - Dispelling taboos, Michelle Obama talks IVF and miscarriage
November 13, 2018 - Medical experts discuss future challenges of healthcare at HSMA’s inaugural conference
November 13, 2018 - Growth and spread of deadly eye tumor suppressed in cells, animals
November 12, 2018 - Study finds huge shortfall in use of home-based medical care by frail seniors
November 12, 2018 - Cocaine Cut With Anti-Worming Drug, Levamisole, May Cause Brain Damage
November 12, 2018 - Obese mice lose a third of their fat using a natural protein
November 12, 2018 - Behind many a Parkinson’s case lurks a mutation in a gene called LRRK2 — why?
November 12, 2018 - Drug with fish oil cuts risk of heart attack, stroke, study finds
November 12, 2018 - Mild exposure to single blast can induce meaningful pathogenic effects, study shows
November 12, 2018 - Miniature pacemakers aim to make heart procedures for infants less invasive, more efficient
November 12, 2018 - Treating pre-cancerous stem cells at early stage could be key to preventing bowel cancer
November 12, 2018 - Kawasaki disease triggered by a combination of factors
November 12, 2018 - Optibrium and University of Nottingham Collaborate on Innovative Teaching Programme
November 12, 2018 - RNA defects linked to multiple myeloma progression in high risk patients
November 12, 2018 - Science is on trial – and we need doctors to provide the defense
November 12, 2018 - Salk researchers receive $19.2 million to unravel mysteries of age-related cognitive decline
November 12, 2018 - KE Eye Centers offer new solution for patients with myopia and astigmatism
November 12, 2018 - Trumpeted new Medicare Advantage benefits will be hard for seniors to find
November 12, 2018 - Biogen and Eisai Announce Presentation of Detailed Analyses from the Phase 1b Long-Term Extension Study of Aducanumab at Clinical Trials on Alzheimer’s Disease (CTAD)
November 12, 2018 - Scientists reveal new cystic fibrosis treatments work best in inflamed airways
November 12, 2018 - Hands-Only CPR training kiosks can teach life-saving skills in just minutes
Heroin addiction treatment and opioid misuse

Heroin addiction treatment and opioid misuse

image_pdfDownload PDFimage_print
Michael Fendrich, associate dean for research and professor at the School of Social Work, on Oct. 12, 2018. Credit: Sean Flynn/UConn Photo

Michael Fendrich is associate dean for research and a professor in the UConn School of Social Work, whose research focuses on policies, services, interventions, and risk factors related to substance misuse and mental health. He recently published a paper about heroin addiction treatment and how it relates to previous opioid misuse history.

Fendrich joined the UConn faculty in 2014, and was previously the director of the Center of Applied Behavioral Health Research at the University of Wisconsin-Milwaukee from 2005 to 2013. He discussed his latest study with UConn Today.

Q. How did you first get interested in the topic of heroin addiction and how it relates to previous opioid history?

A. The increased awareness of the opioid epidemic started five or six years ago, and states were implementing – at the encouragement of the federal government – prescription drug monitoring programs. I was in Milwaukee at the time and was collaborating with a school of pharmacy. I became aware that Wisconsin was one of the last states to implement a prescription drug monitoring program.

I thought this might be a really good opportunity to interview pharmacists and get a sense of what they know about substance abuse and how they view the prescription drug monitoring program. They often come at things with a medical perspective, and – I don’t want to say this in a pejorative way – they don’t always have a clear understanding of some of the behavioral factors. It’s not their world.

It made me interested in figuring out how they would view the opioid crisis, and how they would view the potential issues around people misusing prescription medications, and what their overall knowledge level was about addiction and substance abuse.

In focus groups, we heard things like ‘sometimes I feel like I am more of a policeman than a pharmacist.’ Some pharmacists felt like law enforcement, some felt like health care providers, and some pharmacists felt like they are somewhere in the middle.

Q. What were some of your main findings in your most recent paper on this topic?

A. The big finding was that people [who were undergoing heroin addiction treatment] who had prior opioid history were generally more substance-involved, and they were involved earlier in those substances. They were also more persistent in their opioid use. And they were more likely to suffer some elevated symptoms of depression. So basically, the folks who were heroin dependent with that prior history had more problems than others and they didn’t do as well.

The issue is, does it makes a difference? Yes, it probably does. Those people who progressed in the typical story line that has been described, with opioids and heroin, probably have a more difficult outcome, and – in terms of the potential difficulty of getting us out of this crisis – it points to how problematic this is. It is not just one opioid problem out there, it’s what people’s history contributes to making this a more intractable problem. There are other mental health issues that need to be addressed, especially depression – it’s not just the substance abuse, which everyone is focused on. These mental health issues may mean you need to tailor how you are treating folks. We need other types of intervention that address the conditions people have, especially those that have opioid use before their heroin abuse.

Q. How did this opioid problem get so severe in our society?

A. The story people tell is well-known – an increased availability in prescribed opioid-related medications. That is part of the story. We have other issues going on in society, like lack of opportunity in terms of economic mobility and jobs. There are lots of stressors going on in society and I think those macro-forces have to be considered part of the picture. Everyone says we have a great economy now, but there are a lot of folks who are underemployed, not earning sufficient wages, or don’t have rewarding job opportunities. They haven’t had access to training, and this crosscuts all ethnic groups and all regions: it’s rural, it’s urban.

It’s not, in my opinion, one particular thing that got us into this, and I will also note, there is not going to be one particular thing that’s going to get us out of it. We are going to have to have policies that create job training opportunities, and have access to health care, and access to resources for everybody. We are also going to have to have more restrictive policies toward opioid drugs and opioid drug availability, but by the same token, some of these opioid drugs have been quite beneficial in terms of facilitating pain relief for debilitating conditions. It just needs to be regulated in a way that doesn’t enhance potential for abuse.

Q. So is there hope?

A. Yes, I think so. It is so much on the public radar screen right now. Congress just allocated resources to expand access to treatment. The states, and here in Connecticut the DMHAS (Department of Mental Health and Addiction Services), have been the beneficiary of millions of dollars of funding from the federal government to address the problem. We do have treatment interventions in the form of medication. We have medication to address overdose, like naloxone. It seems like awareness is at a level where it needs to be if we are going to address the problem. The downside is that it seems like in Connecticut and elsewhere, the number of overdose deaths is really very high, and our rates are above the national average in Connecticut in almost every county.

Q. What are you working on now?

A. We are finishing work on a totally different topic – emergency mobile crisis services for children with acute mental health needs. There is a statewide system for kids with this need, and it diverts them from hospital emergency departments. We have a grant to evaluate these services, and whether in fact there is a successful diversion of these kids from the ER. I am really excited about that study.


Explore further:
Any opioid use tied to involvement in criminal justice system

Provided by:
University of Connecticut

Tagged with:

About author

Related Articles